Work

139P Clinical performance of novel exosomal liquid RNA biopsy assay in lung cancer segment

Year: 2026
Type: article
Abstract: Exosomal RNA captures dynamic tumor biology and may overcome limitations of tissue biopsy and imaging, which, in Non-Small Cell Lung Carcinoma (NSCLC), provide high sensitivity but limited PPV and no reliable biomarkers for early recurrence or post-surgical risk stratification. A minimally invasive, real-time assay could improve detection and monitoring.
Source: ESMO Open
Language: English
Open Access status: gold
Estimated APC paid: $3,910
OpenAlex ID: W7147477252
FWCI:
Cites:
Cited by:
Related to: